U2OS PTGFR Bioassay Kit

  • Check with publisher
  • Published date: March 29, 2019
    • Shirley, New York, United States

Bioassay kits provide a robust, highly reproducible and easy-to-use, cell-based functional assay to study receptor activity through a chemiluminescent output. The bioassay kits contain the reagents needed for a functional assay including ready-to-assay cells, plating, dilution & detection reagents, positive control agonist and assay plates. The ready-to-assay kits are designed to accelerate and simplify development of a QC potency assay or a NAb assay for biologic drugs. http://www.creativebiomart.net/U2OS-PTGFR-Bioassay-Kit-463662.htm

Caroline Green
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Recombinant RSV gp G Protein [His]

    Recombinant RSV gp G Protein [His]

    Biomedical Sciences Shirley (New York) March 28, 2019 Check with publisher

    Human respiratory syncytial virus (HRSV) belongs to Paramyxoviridae family. It is a syncytial virus that causes respiratory tract infections. RSV is an enveloped RNA virus with a non-segmented single-stranded negative-sense genome. The disease caused...

  • CPXV Compiegne 2009 antigen

    CPXV Compiegne 2009 antigen

    Biomedical Sciences Shirley (New York) March 25, 2019 Check with publisher

    This virus is classified in the BSL 2 category. This Cowpox virus[Compiegne 2009] is preserved under Freeze Dried (-20°C).Tests for the presence of mycoplasmae were positive, but the product will be provided with a protocol to remove micoplasmae. htt...

  • Analysis/Purification


    Biomedical Sciences Shirley (New York) March 11, 2019 Check with publisher

    Impurities and the unwanted by-products, especially the potentially toxic compounds, should be strictly controlled below a certain level set by the regulatory agencies. That’s mainly ascribed to the fact that these pharmaceutical impurities such as r...